NASDAQ · Financial Statements

Gelteq Limited (GELS) Financial Statements

$0.56 NASDAQ: GELS Market Cap $5.10M

Gelteq Limited most recently reported annual revenue of $0, net profit of $-7.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-1.0M$-3.0M$-3.0M$-3.0M$-5.0M
Net Profit$-1.0M$-3.0M$-4.0M$-4.0M$-7.0M
EPS$-0.07$-0.36$-0.37$0.00$0.00
Op Margin—-2164.4%-3885.3%—-3317.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$24.0M$23.0M$22.0M$21.0M$21.0M
Total Liabilities$0$3.0M$4.0M$6.0M$6.0M
Cash$0$0$0$0$0
Borrowings$0$2.0M$2.0M$4.0M$4.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$0$0$-2.0M$-1.0M$-6.0M
Investing Cash Flow$0$0$0$0$-1.0M
Financing Cash Flow$0$0$0$0$-2.0M
Net Cash Flow$0$0$0$0$0
Free Cash Flow$0$-2.0M$-2.0M$-1.0M$-6.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.02
EV / EBITDA-4.10
FCF Yield0.00%
Quick Ratio0.09
Interest Coverage-3.93
Return 1Y-69.36%
Return 3Y—
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
GELS Overview GELS Dividend Run Stock Screener